Benefits of Nigella Sativa in Children With Beta Thalassemia Major

Clinical trial NCT02816957 · UNKNOWN

Trial details

NCT number: NCT02816957
Sponsor: Tanta University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Nigella Sativa With Beta Thalassemia Major

Start date: 2016-06-01
Primary completion: 2017-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.